Scarica l'app Stockscreener
2.00
12.99%
0.23
Pre-mercato:
1.94
-0.06
-3.00%
Precedente Chiudi:
$1.77
Aprire:
$1.85
Volume 24 ore:
203.54K
Relative Volume:
3.00
Capitalizzazione di mercato:
$3.53M
Reddito:
$957.00K
Utile/perdita netta:
$-6.42M
Rapporto P/E:
-0.6473
EPS:
-3.0899
Flusso di cassa netto:
$-6.13M
1 W Prestazione:
+13.64%
1M Prestazione:
-13.42%
6M Prestazione:
-51.81%
1 anno Prestazione:
-55.54%
Intervallo 1D:
$1.85
$2.2274
Intervallo di 1 settimana:
$1.72
$2.2274
Portata 52W:
$1.47
$15.64
Tivic Health Systems Inc Stock (TIVC) Company Profile
Nome
Tivic Health Systems Inc
Settore
Industria
Telefono
(888)276-6888
Indirizzo
47685 LAKEVIEW BLVD, FREMONT
Confronta TIVC con altri titoli
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
TIVC
Tivic Health Systems Inc
|
2.00 | 3.13M | 957.00K | -6.42M | -6.13M | -3.0899 |
|
ABT
Abbott Laboratories
|
125.40 | 217.86B | 43.84B | 13.90B | 6.92B | 7.9725 |
|
BSX
Boston Scientific Corp
|
97.72 | 146.12B | 19.35B | 2.78B | 3.82B | 1.8696 |
|
SYK
Stryker Corp
|
364.35 | 139.95B | 24.38B | 2.94B | 4.07B | 7.6159 |
|
MDT
Medtronic Plc
|
101.99 | 130.73B | 34.76B | 4.79B | 5.21B | 3.7017 |
|
EW
Edwards Lifesciences Corp
|
85.78 | 48.73B | 5.88B | 1.34B | 799.60M | 2.3489 |
Tivic Health Systems Inc Borsa (TIVC) Ultime notizie
Form 8-KCurrent report - ADVFN
Is Tivic Health Systems Inc. stock cheap compared to fundamentalsTrade Risk Report & Target Return Focused Stock Picks - newser.com
What high frequency data says about Tivic Health Systems Inc.New Guidance & Verified Swing Trading Watchlist - newser.com
Tivic Health secures BARDA meeting for entolimod in ARS - MSN
Why Tivic Health Systems Inc. stock is considered a top pick2025 Technical Patterns & Safe Entry Momentum Stock Tips - newser.com
Tivic Health Shares Rise After US Agency Meeting on Entolimod Set - MarketScreener
12 Health Care Stocks Moving In Tuesday's Intraday Session - Benzinga
Tivic Secures BARDA Meeting for Entolimod(TM) for Acute Radiation Syndrome - ACCESS Newswire
Tivic Health Systems Secures BARDA Meeting for Entolimod - TradingView
[8-K] Tivic Health Systems, Inc. Reports Material Event | TIVC SEC FilingForm 8-K - Stock Titan
Tivic Health (NASDAQ: TIVC) to Present Entolimod ARS Data in BARDA TechWatch Meeting - Stock Titan
Will Tivic Health Systems Inc. stock go up soon2025 Price Momentum & Reliable Volume Spike Trade Alerts - newser.com
Tivic Health’s Earnings Call: Strategic Shift and Challenges - TipRanks
Is OK Play India Limited One of the Top Picks for Growth Investors in YEAREarnings Season Recap & Build Wealth With Strategy - earlytimes.in
Can Tivic Health Systems Inc. stock double in next 5 yearsCPI Data & AI Powered Buy and Sell Recommendations - newser.com
Tivic Health reports finding from clinical optimization trial of ncVNS - MSN
Is Tivic Health Systems Inc. stock trading near support levelsJuly 2025 Selloffs & AI Forecast for Swing Trade Picks - newser.com
Tivic Health Systems Advances Biologics Pipeline - MSN
Tivic Health Systems, Inc. (NASDAQ:TIVC) Q3 2025 Earnings Call Transcript - Insider Monkey
Tivic files patent applications for cancer therapy, nerve stimulation device - MSN
Earnings call transcript: Tivic Health Systems Q3 2025 sees strategic shift - Investing.com Nigeria
Tivic Health Systems Q3 2025 Earnings Call Transcript - MarketBeat
Earnings call transcript: Tivic Health Systems Q3 2025 sees strategic shift By Investing.com - Investing.com South Africa
Tivic Health Systems Shifts Focus to Biopharma Program - TipRanks
Bioelectronic medicine maker Tivic Health's Q3 net loss widens - MarketScreener
TIVC: Shifted focus to biologics, exited consumer health, and secured funding for Entolimod progress - TradingView
Tivic Reports Third Quarter 2025 Financial Results - ACCESS Newswire
Tivic Health (NASDAQ: TIVC) posts third-quarter cash $3.5M, $3.8M financing - Stock Titan
Why Tivic Health Systems Inc. stock is a must watch in 2025Market Performance Summary & Free Safe Entry Trade Signal Reports - Fundação Cultural do Pará
Tivic Health optimizes nerve stimulation parameters in new study By Investing.com - Investing.com Nigeria
Why Tivic Health Systems Inc. stock is a value investor pickOptions Play & Consistent Profit Focused Trading Strategies - newser.com
Tivic Health Unveils Clinical Study Findings - TipRanks
Tivic Health Systems, Inc. Reports Clinical Optimization Study Findings - TradingView
Tivic Health Reports Findings of Clinical Optimization Trial of Non-Invasive Cervical Vagus Nerve Stimulation (ncVNS) - ACCESS Newswire
Tivic Health (NASDAQ: TIVC) reports personalized ncVNS 8.9x more effective for HRV - Stock Titan
Has Tivic Health Systems Inc. formed a bullish divergence2025 Historical Comparison & Free Growth Oriented Trading Recommendations - newser.com
Tivic Health optimizes nerve stimulation parameters in new study - Investing.com
Sentiment analysis tools applied to Tivic Health Systems Inc.2025 Market Sentiment & Expert Verified Movement Alerts - newser.com
Should you wait for a breakout in Tivic Health Systems Inc.Weekly Profit Report & Community Trade Idea Sharing - newser.com
Tivic Health files two new patents for cancer and bioelectronic therapies - Investing.com Australia
Tivic Health files two new patents for cancer and bioelectronic therapies By Investing.com - Investing.com South Africa
BellRing Brands (NYSE: BRBR) narrows outlook to $2.28–$2.32B; updates guidance - Stock Titan
Tivic Expands Intellectual Property Portfolio - The Joplin Globe
Tivic Health Systems Inc Azioni (TIVC) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
2.89%
4.92%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):